jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Basic Full Body

Full Body

66 parameters

image

Report in 24Hrs

image

At Home

fastingrequire

Fasting Required

Details

Essential Health covering Blood, Diabetes, Heart, Liver, Kidney, Thyroid, Iron, Sugar, Inflamation, Bone

₹788₹1,399

44% OFF

Parameters

  • List of Tests
    • Sugar (Glucose) Random
    • CBC - Complete Hemogram
    • Liver Function Test
      • Albumin
      • Alkaline Phosphatase
      • Bilirubin - Direct
      • Bilirubin - Indirect
      • Bilirubin - Total
      • AST/SGOT
      • ALT/SGPT
      • Total Protein
      • A/G Ratio
      • Gamma GT
      • Globulin
    • Kidney Profile
      • BUN
      • Calcium
      • Creatinine
      • Uric Acid
      • eGFR
      • BUN/Creatinine
      • Urea
    • Lipid Profile
      • Cholestrol/HDL
      • LDL/HDL
      • Non HDL
      • VLDL
      • Total Cholestrol
      • Triglycerides
      • HDL
      • LDL
    • Iron Studies
      • Iron
      • TIBC
      • Transferrin Saturation
    • Thyroid Profile
      • Total T3
      • Total T4
      • TSH
    • Hba1c
    • eAG
    • ESR
    • Calcium

Basic Wellness Package - Comprehensive Medical Test Guide

  • Why is it done?
    • Comprehensive health screening to assess overall metabolic, hematologic, hepatic, renal, and endocrine function in asymptomatic individuals
    • Early detection of chronic diseases including diabetes, hypertension, thyroid disorders, anemia, liver disease, and kidney disease
    • Baseline assessment for routine medical check-ups, annual physicals, or preventive health maintenance programs
    • Sugar (Glucose) Random: Screens for hyperglycemia and diabetes mellitus; detects abnormal glucose metabolism
    • CBC - Complete Hemogram: Evaluates red blood cells, white blood cells, and platelets to detect anemia, infection, leukemia, and bleeding disorders
    • Liver Function Test: Assesses liver synthetic and metabolic function; detects hepatitis, cirrhosis, fatty liver disease, and biliary obstruction
    • Kidney Profile: Evaluates renal function and electrolyte balance; detects chronic kidney disease, acute kidney injury, and metabolic abnormalities
    • Lipid Profile: Assesses cardiovascular risk by measuring blood lipids; identifies dyslipidemia and atherosclerosis risk
    • Iron Studies: Evaluates iron metabolism and storage; detects iron deficiency anemia or iron overload disorders
    • Thyroid Profile: Assesses thyroid hormone production and pituitary function; detects hyperthyroidism, hypothyroidism, and thyroid disorders
    • HbA1c and eAG: Provides long-term glycemic control assessment over 2-3 months; evaluates diabetes management and risk
    • ESR (Erythrocyte Sedimentation Rate): Non-specific marker for inflammation; helps identify systemic inflammatory or infectious diseases
    • Calcium: Assesses bone health and parathyroid function; detects hypercalcemia and hypocalcemia-related disorders
    • Tests work synergistically to provide a complete health snapshot, enabling clinicians to identify multiple organ system abnormalities and develop comprehensive treatment strategies
  • Normal Range
    • Sugar (Glucose) Random: 70-100 mg/dL (fasting) or <140 mg/dL (random); Normal indicates adequate glucose control
    • CBC - Complete Hemogram: Hemoglobin: 13.5-17.5 g/dL (males), 12.0-15.5 g/dL (females); RBC: 4.5-5.9 million/μL (males), 4.1-5.1 million/μL (females); WBC: 4,500-11,000/μL; Platelets: 150,000-400,000/μL
    • Liver Function Test: Albumin: 3.5-5.0 g/dL; Alkaline Phosphatase: 30-120 IU/L; Bilirubin Total: 0.1-1.2 mg/dL; Bilirubin Direct: 0.0-0.3 mg/dL; Bilirubin Indirect: 0.1-0.9 mg/dL; AST/SGOT: 10-40 IU/L; ALT/SGPT: 7-56 IU/L; Total Protein: 6.0-8.3 g/dL; A/G Ratio: 1.0-2.5; Gamma GT: 0-65 IU/L; Globulin: 2.0-3.5 g/dL
    • Kidney Profile: BUN: 7-20 mg/dL; Creatinine: 0.7-1.3 mg/dL (males), 0.6-1.1 mg/dL (females); eGFR: >60 mL/min/1.73m²; Uric Acid: 3.5-7.2 mg/dL (males), 2.6-6.0 mg/dL (females); Calcium: 8.5-10.2 mg/dL; Urea: 15-45 mg/dL; BUN/Creatinine Ratio: 10-20
    • Lipid Profile: Total Cholesterol: <200 mg/dL; HDL: >40 mg/dL (males), >50 mg/dL (females); LDL: <100 mg/dL (optimal); Triglycerides: <150 mg/dL; VLDL: <40 mg/dL; LDL/HDL Ratio: <3.0; Cholesterol/HDL Ratio: <5.0; Non-HDL: <130 mg/dL
    • Iron Studies: Iron: 60-170 μg/dL (males), 50-150 μg/dL (females); TIBC: 250-425 μg/dL; Transferrin Saturation: 20-50%
    • Thyroid Profile: Total T3: 80-180 ng/dL; Total T4: 5.0-12.0 μg/dL; TSH: 0.4-4.0 mIU/L
    • HbA1c: <5.7% indicates normal glycemic control; eAG: <100 mg/dL correlates with HbA1c <5.7%
    • ESR: <20 mm/hr (males <50 years), <30 mm/hr (males >50 years), <20 mm/hr (females <50 years), <30 mm/hr (females >50 years)
    • Calcium: 8.5-10.2 mg/dL or 2.1-2.55 mmol/L indicates normal serum calcium levels essential for bone and muscle function
  • Interpretation
    • Sugar (Glucose) Random: Elevated (>140 mg/dL random) suggests hyperglycemia, impaired fasting glucose, or diabetes mellitus; <70 mg/dL indicates hypoglycemia requiring immediate intervention; values 100-125 mg/dL (fasting) suggest impaired fasting glucose
    • CBC - Complete Hemogram: Elevated hemoglobin suggests polycythemia or dehydration; Low hemoglobin (<12 g/dL females, <13.5 g/dL males) indicates anemia; Elevated WBC (>11,000/μL) suggests infection or leukemia; Low WBC (<4,500/μL) indicates immunosuppression; Low platelets (<150,000/μL) suggests thrombocytopenia or bleeding risk
    • Liver Function Test: Elevated AST/ALT (>40 IU/L) indicates hepatocellular injury from hepatitis or cirrhosis; Elevated Alkaline Phosphatase (>120 IU/L) suggests biliary obstruction or bone disease; Elevated bilirubin (>1.2 mg/dL) indicates jaundice, hemolysis, or cholestasis; Low albumin (<3.5 g/dL) suggests malnutrition or liver disease; Elevated Gamma GT suggests alcohol use or biliary disease; Abnormal A/G ratio may indicate liver disease or immune disorders
    • Kidney Profile: Elevated creatinine (>1.3 mg/dL males, >1.1 mg/dL females) indicates reduced glomerular filtration; eGFR <60 mL/min/1.73m² indicates chronic kidney disease; Elevated BUN (>20 mg/dL) suggests renal dysfunction or dehydration; Elevated uric acid indicates gout risk or renal disease; Elevated calcium (>10.2 mg/dL) may cause nephrolithiasis or bone disease; Low calcium (<8.5 mg/dL) indicates hypoparathyroidism or vitamin D deficiency; Elevated BUN/Creatinine ratio (>20) suggests prerenal azotemia
    • Lipid Profile: Total cholesterol >200 mg/dL indicates increased cardiovascular risk; HDL <40 mg/dL (males) or <50 mg/dL (females) is protective factor loss; LDL >100 mg/dL increases atherosclerosis risk; Triglycerides >150 mg/dL indicates hypertriglyceridemia; Elevated LDL/HDL and Cholesterol/HDL ratios suggest poor lipid metabolism; Non-HDL >130 mg/dL indicates atherogenic dyslipidemia
    • Iron Studies: Low iron (<60 μg/dL males, <50 μg/dL females) with high TIBC suggests iron deficiency anemia; Elevated iron (>170 μg/dL males, >150 μg/dL females) with low TIBC indicates hemochromatosis or iron overload; Transferrin saturation >50% suggests iron overload; Transferrin saturation <20% suggests iron deficiency
    • Thyroid Profile: Elevated TSH (>4.0 mIU/L) with low Total T4 indicates primary hypothyroidism; Low TSH (<0.4 mIU/L) with elevated Total T3/T4 indicates hyperthyroidism; Normal TSH with abnormal T3/T4 suggests secondary thyroid dysfunction; Subclinical hypothyroidism shows elevated TSH with normal thyroid hormones
    • HbA1c: 5.7-6.4% indicates prediabetes requiring lifestyle intervention; ≥6.5% confirms diabetes mellitus diagnosis; <5.7% indicates normal glycemic control; Useful for distinguishing acute hyperglycemia from chronic poor control; eAG provides glucose average for better patient understanding
    • ESR: Elevated ESR indicates systemic inflammation, infection, malignancy, or autoimmune disease; Non-specific marker requiring correlation with clinical presentation; Serial measurements help monitor disease activity and treatment response; Mild elevations may occur with age, anemia, or pregnancy
    • Calcium: Hypercalcemia (>10.2 mg/dL) causes polyuria, polydipsia, renal stones, and cardiac arrhythmias; Hypocalcemia (<8.5 mg/dL) causes tetany, seizures, and muscle weakness; Mild variations may reflect albumin changes; Ionized calcium more accurate than total calcium in liver disease or hypoalbuminemia
  • Associated Organs
    • Sugar (Glucose) Random: Pancreas (insulin production), Liver (glucose metabolism), Kidneys (glucose reabsorption); Evaluates endocrine and metabolic function; Abnormalities indicate diabetes mellitus, metabolic syndrome, or insulinoma
    • CBC - Complete Hemogram: Bone marrow (hematopoiesis), Spleen (hemolysis), Lymph nodes (immune function), Lungs (respiratory infection); Evaluates hematologic system; Abnormalities indicate anemia, leukemia, lymphoma, infection, or clotting disorders
    • Liver Function Test: Liver (primary target organ) - all 11 parameters reflect hepatic synthetic, metabolic, and secretory function; Biliary system (bile duct patency), Hemolytic system (bilirubin source); Abnormalities indicate hepatitis, cirrhosis, cholestasis, bile duct obstruction, hemolytic anemia, or hepatic malignancy; Portal hypertension affects albumin and bilirubin levels
    • Kidney Profile: Kidneys (glomerular filtration, tubular reabsorption), Parathyroid glands (calcium-phosphate regulation), Bone (mineral metabolism); eGFR and creatinine assess glomerular filtration; BUN/urea reflect protein metabolism; Calcium imbalances indicate parathyroid or renal disease; Abnormalities indicate chronic kidney disease, acute kidney injury, glomerulonephritis, or secondary hyperparathyroidism
    • Lipid Profile: Liver (lipid synthesis and metabolism), Arterial system (atherosclerosis risk), Heart (coronary artery disease risk), Small intestine (lipid absorption); All lipid parameters synthesized or metabolized by liver; Abnormalities indicate dyslipidemia, metabolic syndrome, or familial lipid disorders; Complications include myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death
    • Iron Studies: Bone marrow (erythropoiesis), Liver (iron storage and ferritin), Spleen (iron recycling from hemolysis), Gastrointestinal tract (iron absorption); Iron, TIBC, transferrin synthesized by liver; Abnormalities indicate iron deficiency anemia, hemochromatosis, or sideroblastic anemia; Complications include anemia, organ fibrosis, or secondary infection
    • Thyroid Profile: Thyroid gland (hormone production), Pituitary gland (TSH secretion), Hypothalamus (TRH secretion); TSH reflects pituitary-thyroid axis integrity; T3 and T4 reflect thyroid hormone production; Abnormalities indicate Graves' disease, Hashimoto's thyroiditis, thyroid cancer, or pituitary dysfunction; Complications include cardiac arrhythmias, myxedema, or thyroid storm
    • HbA1c and eAG: Pancreas (beta cell function and insulin secretion), Red blood cells (hemoglobin glycation), Kidneys (glucose excretion); Reflects average blood glucose over 2-3 months; Helps assess complications risk; Abnormalities indicate diabetes control failure and increased microvascular/macrovascular complication risk
    • ESR: Non-specific systemic inflammation marker affecting multiple organs; Indicates acute or chronic inflammatory/infectious processes; Immune system activation; Malignant disease burden; Abnormalities suggest systemic diseases including rheumatoid arthritis, systemic lupus erythematosus, tuberculosis, endocarditis, or malignancy
    • Calcium: Bones (mineral storage and skeletal integrity), Parathyroid glands (calcium regulation via PTH), Kidneys (calcium reabsorption and vitamin D activation), Intestines (calcium absorption); Maintained within tight range for muscle contraction, nerve conduction, and blood coagulation; Abnormalities indicate parathyroid disease, renal disease, vitamin D deficiency, or bone disease; Complications include osteoporosis, nephrolithiasis, cardiac arrhythmias, or neuromuscular dysfunction
  • Follow-up Tests
    • Sugar (Glucose) Random: Fasting glucose, Oral glucose tolerance test (OGTT), Continuous glucose monitoring (CGM), Insulin level, C-peptide level; Repeat testing annually for prediabetic patients; Every 3-6 months for diabetic patients on treatment
    • CBC - Complete Hemogram: Peripheral blood smear, Bone marrow biopsy (if cytopenias), Reticulocyte count, Vitamin B12 and folate levels, Iron studies; Repeat CBC in 2 weeks for confirmed anemia; Weekly for severe cytopenias; Refer to hematology for WBC >20,000/μL or platelets <50,000/μL
    • Liver Function Test: Liver ultrasound for cirrhosis evaluation, Hepatitis serologies (A, B, C) if jaundiced, Autoimmune hepatitis markers, Prothrombin time (PT/INR), Albumin levels, Alpha-fetoprotein (AFP) for hepatocellular carcinoma screening; Repeat LFTs in 1 week for elevated enzymes; Refer to gastroenterology for persistent elevations
    • Kidney Profile: Renal ultrasound for structural abnormalities, Urine protein-to-creatinine ratio, Urine microscopy, Cystatin C (alternative GFR marker), Renal biopsy (if indicated), 24-hour urine protein; Repeat kidney profile every 3-6 months if eGFR <60; Refer to nephrology if eGFR <30 or rapid decline; Uric acid monitoring in patients on diuretics
    • Lipid Profile: Lipoprotein(a), ApoB, Homocysteine, hsCRP (high-sensitivity C-reactive protein), Carotid intima-media thickness (CIMT), Coronary calcium scoring; Repeat lipid profile in 4-12 weeks after therapy initiation; Annual screening if normal; Refer to cardiology for CIMT >0.75 mm or very high LDL
    • Iron Studies: Serum ferritin, Free iron, Hemoglobin electrophoresis (if suspected hemolytic anemia), Bone marrow biopsy, Liver MRI for iron quantification; Repeat iron studies 1-2 months after treatment initiation; Monitor ferritin every 3 months in hemochromatosis patients; Refer to hematology for severe deficiency or overload
    • Thyroid Profile: Free T3, Free T4, Thyroid antibodies (TPO, thyroglobulin), TSI (thyroid stimulating immunoglobulin), Thyroid ultrasound; Repeat TSH in 6-8 weeks after therapy changes; Annual screening if normal; Monthly monitoring if dose adjustments needed; Refer to endocrinology for TSI positive or thyroid nodules
    • HbA1c and eAG: Fasting glucose, OGTT, HbA1c (every 3-6 months), Home glucose monitoring, Diabetes complications screening (annual eye exam, foot exam, urine albumin); Repeat HbA1c every 3 months until stable, then every 6 months; Annual kidney function assessment; Refer to endocrinology if HbA1c >9% despite treatment
    • ESR: Repeat ESR to track disease progression, Specific inflammatory markers (CRP, procalcitonin), Imaging studies (X-ray, CT, MRI) based on clinical suspicion; Combine with clinical assessment and other labs; Serial ESR measurements assess treatment response; Refer to infectious disease or rheumatology if ESR persistently elevated without clear etiology
    • Calcium: Ionized calcium, Phosphate, Magnesium, Parathyroid hormone (PTH), Vitamin D (25-OH vitamin D), Alkaline phosphatase; Repeat calcium with albumin adjustment; Annual bone density screening (DEXA scan) if low; Vitamin D supplementation if <30 ng/mL; Refer to endocrinology if persistent abnormalities; Parathyroid imaging if high-normal PTH with hypercalcemia
  • Fasting Required?
    • Overall: YES - Fasting 8-12 hours is REQUIRED for optimal test accuracy, particularly for glucose, lipid profile, and kidney function measurements
    • Ideal timing: Collect blood sample in early morning after 8-12 hours fasting (typically 6:00-8:00 AM after overnight fast)
    • Water intake: Clear water only is permitted during fasting period; no other beverages allowed
    • Dietary restrictions: Nothing to eat or drink except water after 10:00 PM the night before; avoid alcohol 24 hours prior to testing
    • Medications: Continue taking all regular medications with small amount of water unless otherwise instructed; especially important for cardiac and blood pressure medications; Inform laboratory technician of all medications
    • Sugar (Glucose) Random: Requires fasting for accurate comparison; Random sample without fasting is acceptable only for screening purposes but less reliable for diagnosis
    • CBC - Complete Hemogram: May be performed non-fasting; minimal food effect; hydration status may affect hematocrit slightly
    • Liver Function Test: May be performed non-fasting; less affected by food intake than lipids; bilirubin relatively stable regardless of fasting
    • Kidney Profile: May be performed non-fasting; creatinine and urea not significantly affected by food; BUN relatively stable
    • Lipid Profile: MUST REQUIRE fasting 8-12 hours; triglycerides significantly elevated if non-fasting; cholesterol minimally affected; LDL calculation requires fasting triglycerides; non-fasting results not comparable to population guidelines
    • Iron Studies: May be performed non-fasting; iron levels may fluctuate with meals but less critical than glucose or lipids; morning collection preferred for consistency
    • Thyroid Profile: May be performed non-fasting; TSH and thyroid hormones not significantly affected by food intake; consistent timing preferred for serial measurements
    • HbA1c and eAG: Non-fasting acceptable; reflects average glucose over 2-3 months; fasting status does not affect results; can be collected anytime during day
    • ESR: May be performed non-fasting; minimal food effect; hydration slightly affects result; ideally collected after morning rest
    • Calcium: May be performed non-fasting; total calcium relatively stable; protein binding may affect results slightly with food intake
    • Special conditions: Inform technician of recent illness, vigorous exercise, or stress (can elevate ESR and some liver enzymes); Report recent transfusions (affect CBC); Disclose herbal supplements or nutritional modifications (affect iron, lipids); Note menstrual cycle if female (affects CBC and iron studies)
    • Test validity: Fasting lipid profile is standard for cardiovascular risk assessment; non-fasting lipid results have different interpretation and are less clinically useful for screening; Repeat testing should maintain same fasting status for comparison

How our test process works!

customers
customers